Holista CollTech Ltd (ASX: HCT) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Holista CollTech Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Holista CollTech Ltd (ASX: HCT)
Latest News
Healthcare Shares
ASIC accuses ASX company of misleading COVID-19 claims
Speculative
Why the Holista CollTech share price is climbing higher today
Share Market News
ASX stock of the day: This small-cap ASX wellness share jumped 6% today after it filed a global patent
Share Gainers
These ASX shares are fighting the spread of coronavirus
⏸️ Investing
The Holista Colltech share price soars 170% today
HCT ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
---|---|---|---|---|---|
YesNo |
About Holista CollTech Ltd
Holista CollTech Ltd is a research-driven biotech company. Its operating segments include Supplements; Ovine Collagen; Infection Control Solutions; Food Ingredients; and Corporate. The supplements segment is involved in the manufacturing and wholesale distribution of dietary supplements. The ovine collagen segment is involved in the manufacturing and distribution of cosmetic grade collagen. The food ingredients segment is involved in the manufacturing and wholesale distribution of healthy food ingredients. The infection control segment is involved in the infection control solutions. The company generates a majority of its revenue from the Supplements segment. Geographically, it generates a majority of its revenue from Malaysia and the rest from Australia and the United States.
HCT Share Price History Data provided by Morningstar.
Date | Close | Change | % Change | Volume | Open | High | Low |
---|---|---|---|---|---|---|---|
20 Nov 2024 | $0.01 | $0.00 | 0.00% | 34,482 | $0.01 | $0.01 | $0.01 |
19 Nov 2024 | $0.01 | $0.00 | 0.00% | 50,000 | $0.01 | $0.01 | $0.01 |
18 Nov 2024 | $0.01 | $0.00 | 0.00% | 100,674 | $0.01 | $0.01 | $0.01 |
14 Nov 2024 | $0.02 | $0.00 | 0.00% | 113,709 | $0.02 | $0.02 | $0.02 |
11 Nov 2024 | $0.02 | $0.00 | 0.00% | 46,512 | $0.02 | $0.02 | $0.02 |
07 Nov 2024 | $0.02 | $0.00 | 0.00% | 270,192 | $0.02 | $0.02 | $0.02 |
05 Nov 2024 | $0.02 | $0.00 | 0.00% | 34,884 | $0.02 | $0.02 | $0.02 |
04 Nov 2024 | $0.02 | $0.00 | 0.00% | 27,407 | $0.02 | $0.02 | $0.02 |
31 Oct 2024 | $0.02 | $0.00 | 0.00% | 25,000 | $0.02 | $0.02 | $0.02 |
30 Oct 2024 | $0.02 | $0.00 | 0.00% | 1,339 | $0.02 | $0.02 | $0.02 |
29 Oct 2024 | $0.02 | $0.00 | 0.00% | 454 | $0.02 | $0.02 | $0.02 |
28 Oct 2024 | $0.02 | $0.00 | 0.00% | 132 | $0.02 | $0.02 | $0.02 |
25 Oct 2024 | $0.02 | $0.00 | 0.00% | 1,226 | $0.02 | $0.02 | $0.02 |
23 Oct 2024 | $0.02 | $0.00 | 0.00% | 191,846 | $0.02 | $0.02 | $0.02 |
Directors & Management Data provided by Morningstar.
Name | Title | Start Date | Profile |
---|---|---|---|
Mr David Ross Deloub | Non-Executive ChairmanNon-Executive Director | Apr 2023 |
Mr Deloub has over 30 years' experience in the finance and corporate sectors. He has held a number of executive positions including Chief Financial Officer at the ASX listed Neptune Marine Services and Executive Director at Patersons Capital Partners, a Perth based boutique advisory firm providing strategic and financial advice to ASX listed companies. David has considerable corporate finance, business development and financial market experience both in Australia the United States and Africa where he has held senior management positions at Alinta Energy Limited , Neptune Marine Services and Alcoa Inc in the US.
|
Mrs Loren (Ann Jones) Anne King | Non-Executive Director | Jul 2021 |
Mrs King has worked in corporate finance and senior administration roles with ASX listed companies, stockbroking and corporate advisory services for the past 18 years. During this time, she gained valuable experience in dealing with all aspects of corporate governance and compliance, specialising in initial public offerings (IPO), backdoor listings, private capital raising and business development.
|
Mr Lai Kwok Kin | Non-Executive Director | Mar 2024 |
Mr Lai is Founder and Managing Director of Singapore-based WeR1 Consultants Pte Ltd which provides counsel for investor relations and crisis communications to companies listed on regional exchanges.
|
Mr Jay Richard Stephenson | Company Secretary | Sep 2021 |
-
|
Jay Richard Stephenson | Company Secretary |
-
|
Top Shareholders Data provided by Morningstar.
Name | Shares | Capital |
---|---|---|
Galen Biomedical Inc | 58,514,245 | 20.99% |
Bnp Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> | 36,305,083 | 13.02% |
818 Corporate Pty Ltd <818 A/C> | 13,544,100 | 4.86% |
Ms Sarinderjit Kaur | 9,675,785 | 3.47% |
Citicorp Nominees Pty Limited | 8,201,949 | 2.94% |
Mr Robert Gemelli | 7,915,016 | 2.84% |
Mr Anthony Robert Ramage | 7,859,500 | 2.82% |
HSBC Custody Nominees (Australia) Limited | 7,829,702 | 2.81% |
Fairview Holdings Pty Ltd <The Manjule Super A/C> | 6,358,570 | 2.28% |
123 Home Loans Pty Ltd | 5,300,000 | 1.90% |
Bnp Paribas Noms Pty Ltd Uobkh A/C R'Miers | 4,258,201 | 1.53% |
Driscoll Future Pty Ltd <Driscoll Super Fund A/C> | 3,750,000 | 1.35% |
Mr Himmat Singh | 3,500,000 | 1.26% |
Chandra Sekaran P Perumal | 3,333,333 | 1.20% |
Ide Super Pty Ltd <Ide Super Fund A/C> | 3,005,221 | 1.08% |
Perpetual Capital Investments Pty Ltd | 3,000,000 | 1.08% |
Jaz Future Fund Pty Ltd <Arr Superannuation Fund A/C> | 2,515,500 | 0.90% |
Mrs Jalpaben Nileshkumar Shah | 2,309,864 | 0.83% |
Hsbc Custody Nominees (Australia) Limited II | 2,131,422 | 0.76% |
Mr Peter Klimis | 1,876,029 | 0.67% |